APA

Docena G., Rovedatti L., Kruidenier L., Fanning A., Leakey N. A. B., Knowles C. H., Lee K., Shanahan F., Nally K., McLean P. G., Di Sabatino A. & MacDonald T. T. (20101029). Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. : Clinical and experimental immunology.

Chicago

Docena G, Rovedatti L, Kruidenier L, Fanning A, Leakey N A B, Knowles C H, Lee K, Shanahan F, Nally K, McLean P G, Di Sabatino A and MacDonald T T. 20101029. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. : Clinical and experimental immunology.

Harvard

Docena G., Rovedatti L., Kruidenier L., Fanning A., Leakey N. A. B., Knowles C. H., Lee K., Shanahan F., Nally K., McLean P. G., Di Sabatino A. and MacDonald T. T. (20101029). Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. : Clinical and experimental immunology.

MLA

Docena G, Rovedatti L, Kruidenier L, Fanning A, Leakey N A B, Knowles C H, Lee K, Shanahan F, Nally K, McLean P G, Di Sabatino A and MacDonald T T. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. : Clinical and experimental immunology. 20101029.